Cargando…

Disease Progression in Patients with Autosomal Dominant Retinitis Pigmentosa due to a Mutation in Inosine Monophosphate Dehydrogenase 1 (IMPDH1)

PURPOSE: Mutations in the inosine monophosphate dehydrogenase 1 (IMPDH1) gene are a common cause of inherited retinal degeneration (IRD). Due to species- and tissue-dependent expression of IMPDH1, there are no appropriate models of human IMPDH1 disease. Therefore, a limited understanding remains of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bennett, Lea D., Klein, Martin, John, Finny T., Radojevic, Bojana, Jones, Kaylie, Birch, David G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Association for Research in Vision and Ophthalmology 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401855/ https://www.ncbi.nlm.nih.gov/pubmed/32821486 http://dx.doi.org/10.1167/tvst.9.5.14

Ejemplares similares

Different Characteristics and Nucleotide Binding Properties of Inosine Monophosphate Dehydrogenase (IMPDH) Isoforms
por: Thomas, Elaine C., et al.
Publicado: (2012)

Fragment-Based Approach to Targeting Inosine-5′-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis
por: Trapero, Ana, et al.
Publicado: (2018)

Newer human inosine 5′-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents
por: Shah, Chetan P., et al.
Publicado: (2018)

Inosine monophosphate dehydrogenase : a major therapeutic target /
Publicado: (2003)

Structure of Pseudomonas aeruginosa inosine 5′-monophosphate dehydrogenase
por: Rao, Vincenzo A., et al.
Publicado: (2013)

Synthesis, in Vitro Evaluation and Cocrystal Structure of 4-Oxo-[1]benzopyrano[4,3-c]pyrazole Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase (CpIMPDH) Inhibitors
por: Sun, Zhuming, et al.
Publicado: (2014)

Inosine monophosphate dehydrogenase type1 sustains tumor growth in hepatocellular carcinoma
por: Jia, Xiaoyuan, et al.
Publicado: (2022)

A Kinetic Alignment of Orthologous Inosine-5′-monophosphate Dehydrogenases
por: Riera, Thomas V., et al.
Publicado: (2008)

Mutations in the TOPORS gene cause 1% of autosomal dominant retinitis pigmentosa
por: Bowne, Sara J., et al.
Publicado: (2008)

A Screening Pipeline for Antiparasitic Agents Targeting Cryptosporidium Inosine Monophosphate Dehydrogenase
por: Sharling, Lisa, et al.
Publicado: (2010)

Inosine monophosphate dehydrogenase 2 as a marker of aggressive and advanced prostate cancer
por: Wieczorek, Paweł, et al.
Publicado: (2018)

Overexpression of Inosine 5′-Monophosphate Dehydrogenase Type II Mediates Chemoresistance to Human Osteosarcoma Cells
por: Fellenberg, Jörg, et al.
Publicado: (2010)

Novel Heterozygous Deletion in Retinol Dehydrogenase 12 (RDH12) Causes Familial Autosomal Dominant Retinitis Pigmentosa
por: Sarkar, Hajrah, et al.
Publicado: (2020)

Gene therapy in animal models of autosomal dominant retinitis pigmentosa
por: Rossmiller, Brian, et al.
Publicado: (2012)

SPP2 Mutations Cause Autosomal Dominant Retinitis Pigmentosa
por: Liu, Yuan, et al.
Publicado: (2015)

Gene Therapy for Rhodopsin-associated Autosomal Dominant Retinitis Pigmentosa
por: Massengill, Michael T., et al.
Publicado: (2021)

SNRNP200 Mutations Cause Autosomal Dominant Retinitis Pigmentosa
por: Zhang, Tao, et al.
Publicado: (2021)

The Efficacy of Mizoribine (Inosine Monophosphate Dehydrogenase Inhibitor) for ANCA-Associated Vasculitis with Hepatitis B Virus Carrier
por: Muratsu, Jun, et al.
Publicado: (2012)

The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis
por: Singh, Vinayak, et al.
Publicado: (2016)

Synthesis and Biological Evaluation of Novel Anti-leukemia Proteolysis-Targeting Chimeras in Degradating Inosine Monophosphate Dehydrogenase
por: Sohbati, Hamidreza, et al.
Publicado: (2022)

Retinitis pigmentosa: mutation analysis of RHO, PRPF31, RP1, and IMPDH1 genes in patients from India
por: Gandra, Mamatha, et al.
Publicado: (2008)

Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa
por: Millington-Ward, Sophia, et al.
Publicado: (2011)

A QSAR model of benzoxazole derivatives as potential inhibitors for inosine 5`-monophosphate dehydrogenase from Cryptosporidium parvum
por: Teotia, Pratibha, et al.
Publicado: (2016)

Epitopes of Immunoreactive Proteins of Streptococcus Agalactiae: Enolase, Inosine 5′-Monophosphate Dehydrogenase and Molecular Chaperone GroEL
por: Dobrut, Anna, et al.
Publicado: (2018)

Molecular characterization of adenosine monophosphate deaminase 1 and its regulatory mechanism for inosine monophosphate formation in triploid crucian carp
por: Zhou, Yonghua, et al.
Publicado: (2022)

Carbocyclic Analogues of Inosine-5’-Monophosphate: Synthesis and Biological Activity
por: Matyugina, E.S., et al.
Publicado: (2012)

Experimental characterization of two archaeal inosine 5'-monophosphate cyclohydrolases
por: Hunter, Caroline A., et al.
Publicado: (2019)

Mutagenetic study of a novel inosine monophosphate dehydrogenase from Bacillus amyloliquefaciens and its possible application in guanosine production
por: Wang, Jian, et al.
Publicado: (2014)

Selection of Pneumocystis jirovecii Inosine 5′-Monophosphate Dehydrogenase Mutants in Solid Organ Transplant Recipients: Implication of Mycophenolic Acid
por: Hoffmann, Claire V., et al.
Publicado: (2021)

Genotyping microarray: Mutation screening in Spanish families with autosomal dominant retinitis pigmentosa
por: Blanco-Kelly, Fiona, et al.
Publicado: (2012)

Mutational screening of splicing factor genes in cases with autosomal dominant retinitis pigmentosa
por: Benaglio, Paola, et al.
Publicado: (2014)

Two novel mutations in PRPF3 causing autosomal dominant retinitis pigmentosa
por: Zhong, Zilin, et al.
Publicado: (2016)

Sectoral activation of glia in an inducible mouse model of autosomal dominant retinitis pigmentosa
por: Massengill, Michael T., et al.
Publicado: (2020)

Myriocin Effect on Tvrm4 Retina, an Autosomal Dominant Pattern of Retinitis Pigmentosa
por: Piano, Ilaria, et al.
Publicado: (2020)

Pharmacological strategies for treating misfolded rhodopsin-associated autosomal dominant retinitis pigmentosa
por: Xi, Yibo, et al.
Publicado: (2021)

Ribavirin suppresses hepatic lipogenesis through inosine monophosphate dehydrogenase inhibition: Involvement of adenosine monophosphate‐activated protein kinase‐related kinases and retinoid X receptor α
por: Satoh, Shinya, et al.
Publicado: (2017)

The purine metabolite inosine monophosphate accelerates myelopoiesis and acute pancreatitis progression
por: Luo, Xiao-Min, et al.
Publicado: (2022)

Mutations in the small nuclear riboprotein 200 kDa gene (SNRNP200) cause 1.6% of autosomal dominant retinitis pigmentosa
por: Bowne, Sara J., et al.
Publicado: (2013)

Complexity of the Class B Phenotype in Autosomal Dominant Retinitis Pigmentosa Due to Rhodopsin Mutations
por: Jacobson, Samuel G., et al.
Publicado: (2016)

Novel PRPF31 mutations associated with Chinese autosomal dominant retinitis pigmentosa patients
por: Xu, Fei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_irb3c92mvae15jl2kbk5cjqg2n